New treatment option in cystic fibrosis: The role of CFTR modulation for patients with a G551D or other gating (class III) mutation – Certificate of Completion

After completing this learning program, participants will be better able to:

1. Appreciate the role of symptomatic treatments in managing patients with CF
2. Describe the mechanism of action of CFTR modulators in clinical management of the disease
3. Identify appropriate patients for currently-available CFTR modulator
4. Communicate the role of CFTR modulators to patients with CF, to maximise adherence over the long term.